274 related articles for article (PubMed ID: 12804439)
1. Amantadine for fatigue in multiple sclerosis.
Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
[TBL] [Abstract][Full Text] [Related]
2. Amantadine for fatigue in multiple sclerosis.
Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
[TBL] [Abstract][Full Text] [Related]
3. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological treatments for fatigue associated with palliative care.
Mücke M; ; Cuhls H; Peuckmann-Post V; Minton O; Stone P; Radbruch L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD006788. PubMed ID: 26026155
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Yang TT; Wang L; Deng XY; Yu G
J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
[TBL] [Abstract][Full Text] [Related]
6. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2010 Feb; (2):CD007280. PubMed ID: 20166093
[TBL] [Abstract][Full Text] [Related]
7. Carnitine for fatigue in multiple sclerosis.
Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial.
Nourbakhsh B; Revirajan N; Morris B; Cordano C; Creasman J; Manguinao M; Krysko K; Rutatangwa A; Auvray C; Aljarallah S; Jin C; Mowry E; McCulloch C; Waubant E
Lancet Neurol; 2021 Jan; 20(1):38-48. PubMed ID: 33242419
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatments for fatigue associated with palliative care.
Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
[TBL] [Abstract][Full Text] [Related]
10. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
Nourbakhsh B; Revirajan N; Waubant E
Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
[TBL] [Abstract][Full Text] [Related]
11. Anti-spasticity agents for multiple sclerosis.
Shakespeare DT; Boggild M; Young C
Cochrane Database Syst Rev; 2001; (4):CD001332. PubMed ID: 11687107
[TBL] [Abstract][Full Text] [Related]
12. Amantadine therapy for fatigue in multiple sclerosis.
Murray TJ
Can J Neurol Sci; 1985 Aug; 12(3):251-4. PubMed ID: 3902184
[TBL] [Abstract][Full Text] [Related]
13. Anti-spasticity agents for multiple sclerosis.
Shakespeare DT; Boggild M; Young C
Cochrane Database Syst Rev; 2003; (4):CD001332. PubMed ID: 14583932
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group.
Can J Neurol Sci; 1987 Aug; 14(3):273-8. PubMed ID: 2889518
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
16. Aminopyridines for symptomatic treatment in multiple sclerosis.
Solari A; Uitdehaag B; Giuliani G; Pucci E; Taus C
Cochrane Database Syst Rev; 2002; (4):CD001330. PubMed ID: 12804404
[TBL] [Abstract][Full Text] [Related]
17. Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.
Garssen MP; Schmitz PI; Merkies IS; Jacobs BC; van der Meché FG; van Doorn PA
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):61-5. PubMed ID: 16361594
[TBL] [Abstract][Full Text] [Related]
18. Treatment for ataxia in multiple sclerosis.
Mills RJ; Yap L; Young CA
Cochrane Database Syst Rev; 2007 Jan; (1):CD005029. PubMed ID: 17253537
[TBL] [Abstract][Full Text] [Related]
19. Aminopyridines for symptomatic treatment in multiple sclerosis.
Solari A; Uitdehaag B; Giuliani G; Pucci E; Taus C
Cochrane Database Syst Rev; 2001; 2002(4):CD001330. PubMed ID: 11687106
[TBL] [Abstract][Full Text] [Related]
20. Amantadine in Parkinson's disease.
Crosby N; Deane KH; Clarke CE
Cochrane Database Syst Rev; 2003; 2003(1):CD003468. PubMed ID: 12535476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]